Document is current

Article History

Received: 28 May 2025

Accepted: 1 September 2025

First Online: 23 September 2025

Declarations

:

: George Han is an Editorial Board member of Advances in Therapy and was not involved in the selection of peer reviewers for the manuscript nor any of the subsequent editorial decisions; is or has been an investigator for Athenex, Boehringer Ingelheim, Bond Avillion, Bristol-Myers Squibb, Celgene, Janssen, Lilly, MC2, Novartis, PellePharm, Pfizer, and UCB and is a consultant, advisor, or speaker for AbbVie, Boehringer Ingelheim, Dermtech, Incyte, Janssen, LEO Pharma, Lilly, Ortho Dermatologics, Pfizer, Regeneron Pharmaceuticals, Sanofi Genzyme, Sun Pharmaceutical Industries, and UCB. April Armstrong has served as a research investigator, scientific advisor, or speaker for AbbVie, Almirall, Amgen, Arcutis, ASLAN Pharmaceuticals, Beiersdorf, Boehringer Ingelheim, BMS, Dermavant, Dermira, EPI, Incyte, Janssen, LEO Pharma, Lilly, Novartis, Ortho Dermatologics, Pfizer, Regeneron Pharmaceuticals, Sanofi, Sun Pharmaceutical Industries, Takeda, and UCB. James G. Krueger reports consulting fees and research support paid to his institution by Abbott Laboratories, Amgen, Boehringer Ingelheim, Bristol-Myers Squibb, Celgene, DBV Technologies, Dermira, EMD Serono, IDEA Pharma, Janssen, LEO Pharma, Lilly, Merck & Co, Novartis, Pfizer, Regeneron Pharmaceuticals, Roche, Sanofi, Sun Pharmaceutical Industries, Valeant Pharmaceuticals, and Vitae Pharmaceuticals. Abby Jacobson is an employee of Bausch Health Companies Inc.

: This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.